Boston Scientific Corporation

Jurisdiction

United States

LEI

Y6ZDD9FP4P8JSSJMW954

ISIN

US1011371077

(BSX)

Sectors

Scores

InsiderPie Expert Score: 64 / 100
Better than peer group:: 53 / 100
Fair value (Benjamin Graham formula): €61.94 33.4% overvalued
Financial strength (Piotroski F-Value): 6 / 9
Fundamental strength relative to industry (Mohanram G-Value): 6 / 7

Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Read full profile

Fundamentals

Net revenue: €15.77B
Gross margin: 68.3%
EBIT: €2.69B
EBIT margin: 17.0%
Net income: €2.14B
Net margin: 13.5%

Statement period: July 1, 2024 - June 30, 2025 (published June 30, 2025)

Estimates

Fiscal Year	Net revenue	Net income
2026	€18.84B +19.4%	€4.35B +103.4%
2027	€20.79B +10.3%	€4.92B +13.2%
2028	€22.90B +10.2%	€5.58B +13.4%

Dividends

No dividend payouts

Analyst ratings

No analyst ratings available

Insider Transactions

Name	Title	Transaction Date	Shares	Price	Value
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	September 2, 2025	-50K	$105.43	-$5.27M
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	August 1, 2025	-17K	$104.63	-$1.81M
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	August 1, 2025	-50K	$104.63	-$5.23M
FUJIMORI YOSHIAKI	N/A	July 29, 2025	-2.9K	$106.99	-$310.38K
LUDWIG EDWARD J	N/A	July 25, 2025	-4K	$106.03	-$424.12K

Congress transactions

Name	Transaction date	Value
Val Hoyle	September 12, 2025	$1.00K–$15.00K
Lisa McClain	September 12, 2025	$1.00K–$15.00K
Gilbert Cisneros	August 14, 2025	$1.00K–$15.00K
Lisa McClain	August 13, 2025	$1.00K–$15.00K
Gilbert Cisneros	July 10, 2025	$1.00K–$15.00K